Definium Therapeutics Inc. Common Shares vs Macy's Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.59B), while Macy's Inc trades at $22.79 (market cap $5.95B). The key difference: Macy's Inc is the larger of the two by market cap, and Macy's Inc pays a 3.36% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Macy's Inc for 58 Days on average.
| DFTX | M | |
|---|---|---|
Market Cap | $4.59B | $5.95B |
Volume | 2,103,937 | 6,030,644 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $26.21 |
52-Week Low | $10.68 | $16.51 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $3.55B | $9.75B |
Dividend Yield | — | 3.36% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Macy's stock trades at $22.79, up 1.47% today, with a bullish technical signal supported by moving averages. The company shows improving fundamentals, with Q2 2026 EPS beating estimates and a raised 2026 outlook. Valuation remains attractive with a P/E of 8.35 and P/S of 0.27, while cash flow trends have strengthened, with net cash flow turning positive in 2024 and 2025. Recent news highlights progress in the 'Bold New Chapter' strategy, focusing on digital and omnichannel growth.
The outlook for Macy's is cautiously optimistic, supported by cheap valuations and strategic initiatives, but risks include competitive pressures and uneven earnings growth. Analyst consensus is mixed with a $24.25 price target, indicating modest upside potential. Key investment opportunities lie in dividend yield and turnaround execution, while risks involve margin pressure and macroeconomic headwinds affecting retail demand.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →